Tuesday, February 28, 2023

Previewing The Vote On ESG Investing, And A Debt Ceiling Update

›
  In his latest note, Stifel's chief Washington Policy Strategist   Brian Gardner , discusses the potential overturn of a DOL rule regar...

Cytokinetics: Complete Response Letter for Heart Failure Therapy Application

›
  Complete Response Letter States that GALACTIC-HF Alone  Does not Establish Substantial Evidence of Effectiveness Sufficient for Approval C...

WHO Was 'Complicit' In China’s Cover-Up Of COVID-19 Origins: Sen. Daines

›
  by Samantha Flom and Melina Wisecup via The Epoch Times , The World Health Organization (WHO) was “complicit” in helping China’s communist...

Transgender Athlete Wins Four Female Running Competitions In A Row

›
  by Paul Joseph Watson via Summit News, A transgender athlete who now identifies as a woman has won four different female running competiti...

GoodRx stock surges 15% after earnings beat

›
  GoodRx Holdings Inc. (GDRX) shares surged in the extended session Tuesday after the consumer-targeted digital healthcare platform topped e...

Novartis halts Pluvicto new patient starts, struggles with supply in manufacturing expansion

›
  For patients with metastatic castration-resistant prostate cancer (mCRPC) who have failed on prior treatments, Novartis’ radiotherapy Pluv...

Bayer grapples with Eylea sales slowdown, sees trend continuing in 2023

›
  On the surface, macular degeneration treatment Eylea continued its juggernaut path in 2022. On Tuesday, when Bayer   reported  fourth quar...